FLUME catheter

K212151 · The Flume Catheter Company, Ltd. · EZL · Nov 3, 2021 · Gastroenterology, Urology

Device Facts

• Record ID: K212151
• Device Name: FLUME catheter
• Applicant: The Flume Catheter Company, Ltd.
• Product Code: EZL · Gastroenterology, Urology
• Decision Date: Nov 3, 2021
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 876.5130
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

The FLUME catheter is intended for the drainage of the urinary tract.

Device Story

The FLUME catheter is a sterile, single-use, indwelling urinary catheter constructed from polyurethane-based polymers. It features a dual-lumen tube: a large lumen for urine drainage and a smaller lumen for inflating/deflating a retention balloon with sterile water. The distal end includes two opposite eye holes for drainage. The device is inserted into the urinary tract to facilitate bladder drainage. The retention balloon is designed to envelop the catheter tip upon inflation, cushioning the bladder wall during emptying to aid in complete drainage. It is intended for use by healthcare professionals in clinical settings. The device is provided sterile and is indicated for an indwelling time of up to 29 days.

Clinical Evidence

No clinical data. Substantial equivalence is supported by non-clinical bench testing, including biocompatibility (ISO 10993), sterilization validation (ISO 11137), package integrity, shelf-life (ASTM F1980-16), and performance testing (ASTM F623-19).

Technological Characteristics

Materials: Polyurethane-based polymers. Design: Two-way lumen, 14 Fr size, 315mm length. Balloon: 5cm3 volume, positioned to envelop tip. Sterilization: Gamma radiation (ISO 11137-2, 10-6 SAL). Connectivity: None. Energy source: None (mechanical).

Indications for Use

Indicated for drainage of the urinary tract in male or female patients requiring an indwelling catheter.

Regulatory Classification

Identification

A urological catheter and accessories is a flexible tubular device that is inserted through the urethra and used to pass fluids to or from the urinary tract. This generic type of device includes radiopaque urological catheters, ureteral catheters, urethral catheters, coudé catheters, balloon retention type catheters, straight catheters, upper urinary tract catheters, double lumen female urethrographic catheters, disposable ureteral catheters, male urethrographic catheters, and urological catheter accessories including ureteral catheter stylets, ureteral catheter adapters, ureteral catheter holders, ureteral catheter stylets, ureteral catheterization trays, and the gastro-urological irrigation tray (for urological use).

Predicate Devices

• Teleflex Rusch All-Silicone Foley Catheter (K980870)

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.

November 3, 2021

The Flume Catheter Company, Ltd. % Elaine Duncan, MS.ME, RAC, FAIMBE President Paladin Medical, Inc. P.O. Box 560 Stillwater, MN 55082

Re: K212151

Trade/Device Name: FLUME catheter Regulation Number: 21 CFR§ 876.5130 Regulation Name: Urological Catheter and Accessories Regulatory Class: II Product Code: EZL Dated: September 29, 2021 Received: September 30, 2021

Dear Elaine Duncan:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies.

{1}------------------------------------------------

Page 2

You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatoryinformation/postmarketing-safety-reporting-combination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email ([e-mail]) or phone [phone] or 301-796-7100).

Sincerely,

Jessica K. Nguyen, Ph.D. Assistant Director DHT3B: Division of Reproductive. Gynecology and Urology Devices OHT3: Office of GastroRenal, ObGyn, General Hospital and Urology Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

# Indications for Use

510(k) Number (if known)

K212151

Device Name FLUME catheter

Indications for Use (Describe)

The FLUME catheter is intended for the drainage of the urinary tract.

Type of Use (Select one or both, as applicable)

| <span style="text-decoration: underline;"></span> Prescription Use (Part 21 CFR 801 Subpart D) | <span style="text-decoration: underline;"></span> |
|------------------------------------------------------------------------------------------------|---------------------------------------------------|
| Over-The-Counter Use (21 CFR 801 Subpart C) | |

#### CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

#### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff [e-mail]

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

510(K) SUMMARY FLUME catheter

### Submitted on behalf of:

| Company Name:<br>Contact Name: | The Flume Catheter Company Ltd.<br>Roger Holmes |
|--------------------------------|---------------------------------------------------------------------------|
| Address: | The Granary, Mill House<br>Frensham, Farnham, GU10 3EE,<br>United Kingdom |
| Telephone: | 44(0) 207 808 9125 |
| by: | Paladin Medical, Inc.<br>PO Box 560<br>Stillwater, MN 55082 |
| Telephone: | 715-549-6035 |
| CONTACT PERSON: | Elaine Duncan, MSME, RAC, FAIMBE<br>President, Paladin Medical, Inc. |
| DATE PREPARED: | November 3, 2021 |
| TRADE NAME: | FLUME catheter |
| COMMON NAME: | Catheter, Retention Type, Balloon |
| REGULATION NAME: | Urological Catheter and Accessories |
| REGULATION NUMBER: | 876.5130 |
| REGULATORY CLASS: | II |
| PRODUCT CODE: | EZL |

### PREDICATE DEVICE:

Teleflex Rusch All-Silicone Foley Catheter (K980870)

### DESCRIPTION of the DEVICE:

The FLUME catheter is intended for the drainage of the urinary tract. The FLUME catheter is a sterile indwelling urinary catheter intended for single use. The FLUME catheter is made using polyurethane-based polymers. The catheter has an inflatable retention balloon attached to the catheter has a dual lumen tube. The larger lumen is for draining urine from the urinary tract. The smaller lumen is used to inflate and deflate the balloon with sterile water. The distal end has two opposite eye holes, which are used for drainage. The product is available in size 14 Fr with a smooth shaft.

#### INDICATIONS FOR USE:

The FLUME catheter is intended for the drainage of the urinary tract.

### SUBSTANTIALLY EQUIVALENT TO:

The FLUME catheter is substantially equivalent to Teleflex Rusch All-Silicone Foley Catheter K980870.

{4}------------------------------------------------

# Comparison of Technological Characteristics with Predicate Device

| Attribute | Rusch Silicone Foley<br>Catheter | FLUME catheter | Similarities and<br>Differences |
|----------------------------|-------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Classification Name | Catheter, Retention<br>Type, Balloon | Catheter,<br>RetentionType,<br>Balloon | SAME |
| Produce Code | EZL | EZL | SAME |
| Regulation Number | 876.5130 | 876.5130 | SAME |
| Class | 2 | 2 | SAME |
| Indication for Use | The Rusch Silicone<br>Foley is used to drain<br>fluids to and from the<br>urinary tract | The FLUME catheter<br>is intended for the<br>drainage of the<br>urinary tract | FLUME catheter is<br>only offered as a<br>two-lumen catheter,<br>drainage only |
| Intended Population | Male or female | Male or female | SAME |
| Lumen | Two-way: lumen to<br>fill balloon, lumen to<br>drain bladder. | Two-way: lumen to fill<br>balloon, lumen to<br>drain bladder | SAME |
| Indwelling Time | Maximum indwell<br>time of 29 days | Maximum indwell<br>time of 29 days | SAME |
| Single use or reusable | Single use | Single use | SAME |
| Size Ranges | Shaft sizes 8Fr to<br>26Fr, Net effective<br>length 285mm for the<br>standard Teleflex<br>Rusch. | Shaft size 14Fr,<br>i.e.,outer diameter<br>of 4.7mm. Net<br>effective length of<br>315mm. | The difference in<br>length does not affect<br>the safety and<br>effectiveness<br>compared to the<br>predicate device. |
| Balloon Volume | 5cm3 | 5cm3 | SAME |
| Balloon positioning | Below/proximal of the<br>catheter tip and drain<br>holes | Envelops catheter<br>tip and positioned<br>lateral to drain<br>holes. | The FLUME balloon<br>is positioned so that<br>it envelops the tip at<br>the time of inflation,<br>cushioning the<br>bladder wall on<br>emptying and aids<br>full drainage of the<br>bladder. |
| Balloon attachment | Bonded to catheter<br>shaft, around full<br>circumference of<br>both ends of the<br>balloon component | Bonded to<br>cathetershaft for<br>half the<br>circumference of<br>both ends of the<br>balloon component | Testing shows<br>differences do not<br>affect safety and<br>effectiveness<br>compared to the<br>predicate device. |
| Sold Sterile and Method | Ethylene Oxide 10-6<br>SAL | Gamma; ISO 11137-<br>2; 10-6 SAL | Met requirements |
| Biocompatibility/materials | Silicone | ISO 10993;<br>polyurethanes | Materials differences<br>do not introduce new<br>risks, meets ISO<br>10993 |
| Tip shape | Rounded, tapered | Rounded, tapered | SAME |
| Drain holes | Two opposite<br>eyeholes at distal<br>end | Two opposite<br>eyeholes at distal end | SAME |
| Drainage connector | Funnel | Funnel | SAME |
| Check valve | Luer activated<br>valve | Luer activated<br>valve | SAME |

{5}------------------------------------------------

## SUMMARY of NON CLINICAL TESTING:

- Biocompatibility was conducted per International Standard ISO 10993-1, "Biological . Evaluation of medical devices – Part 1: Evaluation and Testing within a risk management process:
- Cytotoxicity, .
- . Sensitization.
- . Irritation.
- . Acute Systemic Toxicity,
- . Subacute Systemic Toxicity.
- Material Mediated Pyrogenicity .
- Subcutaneous Implantation,
- . Genotoxicity.
- Sterilization validation was conducted per the following FDA-recognized standards: ●
- ISO 11137-1:2006/(R)2015, Sterilization of health care products Radiation Part 1: . Requirements for development, validation and routine control of a sterilization process for medical devices.
- . ISO 11137-2:2013, Sterilization of health care products - Radiation - Part 2: Establishing the sterilization dose
- . Transportation simulation, package integrity and shelf-life were conducted to demonstrate that the subject device packaging materials can withstand the rigors of shipping and distribution and maintain the integrity of the sterile barrier during transportation and its proposed shelf life. Accelerated aging was performed in conformance with ASTM F1980-16, Standard Guide for Accelerated Aging of Sterile Barrier Systems for Medical Devices.
- . Performance/Functional testing was conducted per ASTM F623-19 Standard Performance Specification for Foley Catheter.

CONCLUSION: The non-clinical testing provided support that the FLUME catheter is substantially equivalent to the predicate device.